PolyPeptide Group

PolyPeptide Group is a leading Contract Development & Manufacturing Organization (CDMO) specializing in the development and manufacturing of synthetic peptides and oligonucleotides. These are used as active pharmaceutical ingredients (API) or intermediates in therapeutic products. PolyPeptide also produces a range of generic peptides and peptides used in cosmetics, serving pharmaceutical and biotech companies worldwide.

Established in 1952, PolyPeptide Group operates a global network of GMP-certified facilities across Europe, the U.S., and India. The company's commitment extends from pre-clinical stages through to commercial manufacturing, supporting the health of millions of patients globally. Primary operations are based at Neuhofstrasse 24, Baar, CH, with additional locations including Limhamnsvägen 108, Malmö, Skåne 20061, SE; 365 Maple Ave, Torrance, CA 90503, US; Chaussee De Tubize 297, Braine-l'Alleud, Nivelles 1420 , BE; K 28 Additional MIDC, Anand Nagar, Ambernath, Thane, Maharashtra 421506, IN; 9395 Cabot Dr, San Diego, CA 92126, US; and 7 Rue de Boulogne, Strasbourg, . 67100 , FR.

PolyPeptide Group continues to drive innovation in personalized medicine and green chemistry. With a focus on regulatory support and GMP compliance, PolyPeptide ensures the highest standards in active pharmaceutical ingredient development and manufacturing. We invite the management team at PolyPeptide Group to create a customized and exclusive company showcase and product listing on our platform to further highlight your capabilities.